Condition
Colorectal Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 47 Colorectal Carcinoma clinical trials that are recruiting, at sites in 19 countries (most in United States (28), China (8), Spain (3)). By phase: Phase 2 (8), Phase 1 (5), Phase 1/2 (3), Phase 4 (1). The most active sponsors are Mayo Clinic (4), National Cancer Institute (NCI) (3), Memorial Sloan Kettering Cancer Center (2). There are also 6 NIH-funded research projects on Colorectal Carcinoma, with $5.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 47Clinical trials
- 6NIH research projects
- 19Countries
Newest Colorectal Carcinoma clinical trials
All recruiting trials (47)
-
Exercise after pelvic radiation to see if it lowers colorectal cancer risk
This study tests whether regular walking therapy after pelvic radiation for prostate cancer can influence markers of colorectal cancer in colon tissue and blood.
-
Irreversible Electroporation for Recurrent Pelvic Tumors
This study tests whether using irreversible electroporation (IRE) is safe and helps control recurrent pelvic tumors in adults who can’t have other local treatments.
-
Smart Symptom Tracking with ALEX for GI Health in Young Adults
This trial tests whether the Smart Symptom Tracking ALEX app can better track GI symptoms in young adults (18–44) compared with standard paper logs.
-
Culturally adapted online genetic counseling and testing education for African American cancer survivors
We will test a culturally adapted online genetic counseling program to see if it increases genetic counseling and genetic testing among African American breast, prostate, and colorectal cancer survivors.
-
Zanidatamab given before surgery for HER2-positive colon or rectal cancer
This tests whether giving zanidatamab before surgery helps adults with HER2-positive, RAS‑wildtype colon or rectal cancer who are planned for curative treatment.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
-
Zanidatamab for solid tumors with HER2 changes
This study will try zanidatamab, an anti-HER2 drug, in adults with advanced endometrial, colorectal, head and neck, sarcoma, or non-small cell lung cancer whose tumors have specific HER2 changes.
-
Rectus sheath catheters after midline abdominal surgery
This study tests whether using rectus sheath catheters with local anesthetic provides better pain relief after midline laparotomy compared with a placebo in adults.
-
p16 protein expression in colorectal cancer and its links to clinical and pathological features
This project will test whether p16 protein levels and staining patterns in tumor tissue from people with colorectal cancer link to features such as age, tumor site, histologic type, lymph node status, and nerve or vessel invasion.
-
Blood markers to better sort who needs urgent colorectal testing
This will test whether a blood test measuring hPG80 and mobile genetic elements can spot colorectal cancer or polyps in adults referred for urgent bowel investigations.
-
CP-383 for advanced or metastatic solid tumors
This trial tests whether the oral drug CP-383 can slow or stop growth in adults with advanced or metastatic solid tumors who have exhausted standard treatments.
-
Vanguard: a new blood test approach to screen for multiple cancers
This study will test two different blood-based multi-cancer detection tests in adults 45–75 without cancer to see if they find cancers earlier than usual care.
-
Preserving the rectum in patients with rectal cancer using targeted radiation therapy
This study is testing if targeted radiation therapy can help patients with rectal cancer avoid surgery while still keeping their cancer under control.
-
CAR-T therapy targeting CDH17 for advanced solid tumors
This study is testing a new CAR-T cell therapy aimed at treating advanced solid tumors that have a specific marker called CDH17 in patients who have run out of other treatment options.
-
Comparing two pain relief methods for open colon surgery
This study is testing whether a single dose of spinal morphine or continuous epidural pain relief works better for managing pain after open colon surgery for cancer patients.
-
Evaluation of a new robotic surgical system for major gastrointestinal and urologic surgeries
This study is testing a new robotic surgery system to see if it can safely and effectively help patients with major gastrointestinal and urologic conditions like colorectal and prostate cancer.
-
Blood test for early diagnosis of colorectal cancer
This study is testing a new blood test to see if it can help find colorectal cancer and advanced polyps earlier in people who are at risk.
-
Short-course radiation plus CAPEOX chemotherapy and serplulimab for MSS/pMMR rectal cancer with limited metastases
This trial will try combining short-course radiotherapy, CAPEOX chemotherapy, and the immunotherapy serplulimab to see if it helps people with MSS/pMMR rectal cancer who have a small number of metastases.
-
Multilevel approach to boost follow-up colonoscopy after abnormal FIT
This trial tests a multilevel program to help people with abnormal FIT results complete a follow-up colonoscopy.
-
Testing MGC028 in patients with advanced solid tumors
This study is testing a new treatment called MGC028 to see if it is safe and can help adults with advanced solid tumors that can't be removed or have spread.
-
Evaluating PreveCol for Early Detection of Colorectal Cancer
This study is testing a new blood test called PreveCol to see if it can help find colorectal cancer and advanced polyps in people aged 50-69 who have already had a positive stool test.
-
Digital system to improve postoperative care for colorectal cancer patients
This study tests a digital follow-up platform for adults who had colorectal cancer surgery to see if it improves how well they stay in touch with care and feel supported.
-
Improving colorectal cancer screening in primary care clinics
This study is testing two different ways to improve colorectal cancer screening rates in primary care clinics to see which one helps more people get screened.
-
Program to increase cancer screening among low-income women in Central Ohio
This study is trying to see if a new program can help low-income women in Central Ohio get better access to cancer screenings for breast, cervical, and colorectal cancers.
-
Treatment model for colorectal cancer using ambulatory surgery
This study tests whether a less invasive day surgery for colorectal cancer can lead to fewer complications and better long-term results for generally healthy patients compared to traditional surgery.
-
Combination treatment for advanced colorectal cancer with BRAF V600E mutation
This study is testing a new combination treatment for advanced colorectal cancer with a specific mutation to see if it works better than the usual treatment.
-
Primary Care–GI Connect to improve colonoscopy follow-up after an abnormal FIT
This trial tests whether a clinic-wide Primary Care–GI Connect program helps patients at community health centers get colonoscopies within six months after an abnormal fecal immunochemical test (FIT).
-
TPST-1495 treatment for people with familial adenomatous polyposis
This trial will try an oral drug called TPST-1495 to see if it reduces the number of polyps in the small bowel and colon in people with familial adenomatous polyposis.
-
Examining the effects of cannabis use in cancer patients undergoing treatment
This study is trying to see how using cannabis affects newly diagnosed cancer patients who are starting treatment for their illness.
-
Improving colonoscopy follow-up for patients with high risk colon polyps
This study is testing whether better reminders and support for scheduling can help patients with high risk colon polyps get their follow-up colonoscopies done on time to lower their chances of developing colorectal cancer.
-
T cell therapy targeting KRAS G12D in advanced solid tumors
This trial will test whether autologous T cells engineered to recognize KRAS G12D can help adults with unresectable or metastatic solid tumors who have the matching HLA type.
-
Activating the immune response to treat advanced colorectal and breast cancer
This study is testing a new immune treatment combined with radiation to see if it can help people with advanced colorectal or breast cancer that can't be surgically removed.
-
Understanding colorectal cancer in Hispanic patients
This study looks at Hispanic patients with colorectal cancer to see how their genes and gut health affect their treatment and outcomes.
-
Treatment with engineered T cells for advanced solid tumors with a specific mutation
This study is testing a new T cell therapy for patients with advanced solid tumors that have a specific mutation to see if it can help fight their cancer.
-
Evaluating BDTX-4933 for patients with specific cancer mutations
This study is testing a new drug called BDTX-4933 to see if it can help adults with advanced cancers that have certain gene mutations feel better and improve their treatment options.
-
Web-based support for colorectal cancer patients and their caregivers
This study is testing a new online support program to help colorectal cancer patients and their caregivers manage symptoms like fatigue and depression during chemotherapy.
-
ONC201 (dordaviprone) for safety and prevention of colorectal polyps in high-risk adults.
This trial tests whether different doses of ONC201 (dordaviprone) are safe and can help prevent new colorectal polyps in adults with familial adenomatous polyposis or a history of multiple adenomas.
-
Improving colorectal cancer screening in Black and underserved communities in Phoenix
This study is trying to improve colorectal cancer screening for Black and underserved communities in Phoenix by offering free at-home tests and support to help people get the care they need.
-
Collecting blood and stool samples to detect colorectal cancer in Lynch syndrome patients
This study is testing a new stool DNA test to see if it can help find colorectal cancer in people with Lynch syndrome by collecting their blood and stool samples.
-
Using PD-1 antibody for treating advanced colorectal cancer
This study is testing if a PD-1 antibody can help people with advanced colorectal cancer that has certain genetic features stay cancer-free after surgery, compared to a standard chemotherapy combination.
-
Neoantigen vaccine combined with nivolumab for liver cancer treatment
This study is testing a personalized vaccine combined with a cancer drug to see if it can help people with liver cancer stay cancer-free after surgery.
-
Tegavivint treatment for recurrent or refractory solid tumors in children
This study tests if a new intravenous medication called tegavivint can help children with tough-to-treat solid tumors, like Ewing sarcoma and desmoid tumors, by finding the right dose and seeing how well it works.
-
Impact of cancer treatments on reproductive and sexual health in young colorectal cancer patients
This study looks at how chemotherapy and radiation therapy affect the reproductive and sexual health of young people with early onset colorectal cancer.
-
Understanding how diet influences the gut microbiome and colorectal cancer risk
This study looks at how different diets, like vegetarian or omnivore, affect the gut bacteria and the risk of developing colorectal cancer.
-
Understanding young onset colorectal cancer
This study is trying to gather information from people with colorectal cancer to see how cases in younger patients under 50 are different from those diagnosed after 50.
-
A wait-and-see approach for rectal cancer patients after treatment
This study is testing whether some rectal cancer patients who respond well to treatment can safely skip surgery and just be closely monitored instead.
-
Identifying biomarkers and treatment strategies for peritoneal surface malignancies
This study is trying to find specific markers in patients with peritoneal surface cancers to help choose the best treatment options and improve their chances of recovery.
NIH-funded research (6)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
BVES protein in colorectal cancer: stopping tumor spread by stabilizing cell junctions
This grant explores how BVES, a protein at cell junctions, prevents colorectal cancer cells from becoming more aggressive and how restoring BVES could lead to new ways to stop tumor growth.
-
Ensemble deep learning to detect tumor buds and judge risk in colorectal cancer
A computer tool will help doctors identify tumor buds in colorectal cancer slides and use that information to better estimate a patient’s prognosis.
-
extracellular RNA in colorectal cancer: how RNAs travel between cells and impact tumors
A broad research program at Vanderbilt is studying how extracellular RNAs travel between cancer cells in colorectal cancer and influence tumor growth and treatment response.
-
Using AI to Improve Colorectal Cancer Prognosis
This project is creating a smart computer system to find tiny groups of cancer cells in colon tissue, helping doctors better understand a patient's colorectal cancer.
-
Using deep learning to detect tumor buds in colorectal cancer.
This study is working on a smart computer program that helps doctors spot tiny signs of tumor growth in colorectal cancer, which can help predict how well patients might do, so they can make better treatment choices.
-
Understanding how RNA communication affects colorectal cancer
This study is looking at how tiny pieces of RNA found outside of cells might affect the growth and spread of colorectal cancer, with the hope that understanding this could lead to new treatments for patients.
Related topics
Quick answers
How many Colorectal Carcinoma clinical trials are recruiting right now?
47, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 19 countries. The most sites are in United States (28 trials), China (8 trials), Spain (3 trials), Canada (2 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 8, Phase 1: 5, Phase 1/2: 3, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.